Missouri Network For Opiate Reform And Recovery

Missouri Network For Opiate Reform And Recovery operates as a federal grant sub-recipient, delivering harm reduction and infectious disease prevention services to people who inject drugs through syringe services programs (SSPs) and related capacity-building work under grants administered by the Centers for Disease Control and Prevention. The organization is a tax-exempt nonprofit entity headquartered in St. Louis, Missouri, and has received three sub-award grants totaling $248 thousand since April 2023, all routed through federal grant recipients rather than direct federal contract or grant primes.

The vendor's federal footprint consists entirely of harm reduction and infectious disease prevention work. The two customer agencies represented in the award portfolio are the Centers for Disease Control and Prevention, which accounts for all three sub-awards under different grant programs. The most recent award, dated April 1, 2024, directed sub-funding through the National Alliance of State and Territorial AIDS Directors to support the capacity of the infectious disease workforce in partnership with SSPs, expanding national technical assistance for health departments and community-based organizations and scaling up syringe services across the United States. A prior award from April 12, 2023, channeled funding through the Missouri Department of Health and Senior Services to sustain, develop, and implement harm reduction activities within Missouri. An earlier award, dated April 1, 2023, also routed through the National Alliance of State and Territorial AIDS Directors, funded Missouri Network For Opiate Reform And Recovery's participation as a directly funded SSP in a COVID-19 vaccination and infectious disease prevention demonstration project, expanding screening, vaccination, and comprehensive services to people who inject drugs.

Activity has remained modest — two awards in 2023 and one in 2024 — with no recompete exposure or parent IDV vehicles. The organization operates exclusively as a sub-recipient on federal grant programs; it holds no prime contract or grant awards and is not positioned on any government-wide acquisition vehicles or agency-specific IDIQs.